Is the use of intranasal glucocorticosteroids (inGCSs) in children safe?
Journal Title: Otolaryngologia Polska - Year 2015, Vol 69, Issue 1
Abstract
It’s been 40 years since Niels Mygind publication in British Medical Journal on intranasal application of beclomethasonedipropionate aerosol in Allergic Rhinitis. Since then the new era in treatment of allergic and non-allergic upper airway diseases has begun.This publication presents current concepts on application of intranasal glucocorticosteroids in treatment of upper airway diseases and in particular of allergic rhinitis and rhinosinusitis.The non-questionable advantage of intranasal glucocorticosteroids is their strong anti-inflammatory local action with little impact on general health responsible for few and benign side effects. Main way of action of glucocorticosteroids is connected with binding to the intracellular glucocorticosteroid receptor and its impact on nuclear cytoplasmic transcriptional factors. Glucocorticosteroids suppress gene expression of factors responsible for generating and supporting inflammatory processes, pro-inflammatory cytokines and chemokines production, adhesive molecules expression. It appears that glucocorticosteroids has also other mechanisms of action, non-involving intracellular receptors, leading to inhibiting of early and late phase of allergic reaction.At the moment there are following glucocorticosteroids registered in Poland: beclomethasone, budesonide, fluticasone propionate, fluticasone fuorate, mometasonefuorate. Special attention earns fuorates as their lateral fuorate ester chain makes this molecules highly lipophilic, easily absorbed by nasal mucous membranes epithelium and cell membranes phospholipids. This minimizes their general action and maximizes local action. According to current state of knowledge topical glucocorticosteroids are used in the following upper airway diseases with different inflammatory mechanism: allergic rhinitis, non-allergic rhinitis, particularly NARES, acute rhinosinusitis, chronic rhinosinusitis with and without nasal polyps, adenoid hypertrophy and rhinitis in bronchial asthma.
Authors and Affiliations
Anna Nowicka, Bolesław Samoliński
Keywords
Related Articles
- EP ID EP52575
- DOI -
- Views 108
- Downloads 0
Nasal manifestations of systemic dieseases
Vocal fold paralysis in the Medical University of Warsaw's Ambulatory of Phoniatry in years 2000-2011
Introduction: Vocal fold paralysis it is an important problem in Phoniatrics' Ambulatory. There are a lot of difficulties in estimation a precise incidence of vocal fold paralysis in the population. As many as 50% of cas...
Ograniczona choroba Castelmana o łagodnym przebiegu klinicznym
tylko w jezyku angieslkim
Ocena diagnostyki chorób zawodowych narządu głosu w I i II instancji na materiale IMP i ZŚ w Sosnowcu w latach 2002–2005
Introduction: An amendment of the Polish Occupational Diseases Certification Act of 2002 has essentially influenced on the procedures of diagnosis and certifi cation. Aim: The aim of the study was to assess the diagnosti...
Wewnątrzczaszkowe powikłania zatokopochodne u pacjentów Oddziału Otolaryngologicznego Szpitala Wojewódzkiego w Olsztynie leczonych w latach 2004–2007
Sinusitis is common disease. However intracranial complications of sinusitis are rare, but they are still a serious problem that results in high mortality. Diagnostic advantages of CT scanning and magnetic resonance imag...